SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-024218
Filing Date
2023-05-12
Accepted
2023-05-11 19:26:02
Documents
17
Period of Report
2023-05-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc20052804_8k.htm   iXBRL 8-K 63527
2 EXHIBIT 2.1 brhc20052804_ex2-1.htm EX-2.1 592815
3 EXHIBIT 10.1 brhc20052804_ex10-1.htm EX-10.1 71248
4 EXHIBIT 99.1 brhc20052804_ex99-1.htm EX-99.1 12479
5 EXHIBIT 99.2 brhc20052804_ex99-2.htm EX-99.2 22706
9 image001.jpg GRAPHIC 7067
  Complete submission text file 0001140361-23-024218.txt   1061104

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA cycn-20230511.xsd EX-101.SCH 3868
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE cycn-20230511_lab.xml EX-101.LAB 23290
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cycn-20230511_pre.xml EX-101.PRE 16554
11 EXTRACTED XBRL INSTANCE DOCUMENT brhc20052804_8k_htm.xml XML 4222
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
Cyclerion Therapeutics, Inc. (Filer) CIK: 0001755237 (see all company filings)

IRS No.: 831895370 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38787 | Film No.: 23912734
SIC: 2834 Pharmaceutical Preparations